Interpace Biosciences, Inc. (IDXG)
1.43
-0.09
(-6.09%)
USD |
OTCM |
Aug 24, 16:00
Interpace Biosciences 1 Year Total Returns (Daily) : 62.50% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 62.50% |
| August 21, 2026 | 73.05% |
| August 20, 2026 | 62.63% |
| August 19, 2026 | 72.96% |
| August 18, 2026 | 76.27% |
| August 17, 2026 | 71.72% |
| August 14, 2026 | 74.74% |
| August 13, 2026 | 92.46% |
| August 12, 2026 | 77.35% |
| August 11, 2026 | 89.66% |
| August 10, 2026 | 100.0% |
| August 07, 2026 | 90.42% |
| August 06, 2026 | 90.70% |
| August 05, 2026 | 77.31% |
| August 04, 2026 | 94.05% |
| August 03, 2026 | 91.57% |
| July 31, 2026 | 76.40% |
| July 30, 2026 | 60.80% |
| July 29, 2026 | 64.72% |
| July 28, 2026 | 72.50% |
| July 27, 2026 | 71.60% |
| July 24, 2026 | 53.68% |
| July 23, 2026 | 42.16% |
| July 22, 2026 | 54.08% |
| July 21, 2026 | 67.16% |
| Date | Value |
|---|---|
| July 20, 2026 | 73.24% |
| July 17, 2026 | 58.03% |
| July 16, 2026 | 58.97% |
| July 15, 2026 | 68.75% |
| July 14, 2026 | 84.05% |
| July 13, 2026 | 86.52% |
| July 10, 2026 | 110.3% |
| July 09, 2026 | 110.0% |
| July 08, 2026 | 103.1% |
| July 07, 2026 | 113.6% |
| July 06, 2026 | 114.3% |
| July 02, 2026 | 113.0% |
| July 01, 2026 | 113.2% |
| June 30, 2026 | 117.3% |
| June 29, 2026 | 125.4% |
| June 26, 2026 | 135.7% |
| June 25, 2026 | 134.3% |
| June 24, 2026 | 139.4% |
| June 23, 2026 | 124.3% |
| June 22, 2026 | 111.7% |
| June 18, 2026 | 116.5% |
| June 17, 2026 | 113.6% |
| June 16, 2026 | 121.1% |
| June 15, 2026 | 105.9% |
| June 12, 2026 | 128.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Exlites Holdings International, Inc. | -41.74% |
| Xcelerate, Inc. | -34.81% |
| Vivos Therapeutics, Inc. | -93.41% |
| Hinge Health, Inc. | 56.30% |
| PD-Rx Pharmaceuticals, Inc. | 21.82% |